Study of Arbaclofen for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders
Public ClinicalTrials.gov record NCT01288716. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders
Study identification
- NCT ID
- NCT01288716
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Seaside Therapeutics, Inc.
- Industry
- Enrollment
- 150 participants
Conditions and interventions
Conditions
Interventions
- Arbaclofen Drug
Drug
Eligibility (public fields only)
- Age range
- 5 Years to 21 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2011
- Primary completion
- Jul 31, 2012
- Completion
- Aug 31, 2012
- Last update posted
- Jul 30, 2013
2011 – 2012
United States locations
- U.S. sites
- 24
- U.S. states
- 18
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Southwest Autism Research & Resource Center | Phoenix | Arizona | 85006 | — |
| University of California-Los Angeles Neuropsychiatric Institute | Los Angeles | California | 90024 | — |
| University of California-Davis, M.I.N.D. Institute | Sacramento | California | 95817 | — |
| Pharmax Research Clinic | Miami | Florida | 33126 | — |
| Lake Mary Pediatrics | Orange City | Florida | 32763 | — |
| Institute for Behavioral Medicine | Smyrna | Georgia | 30080 | — |
| Institute for Juvenile Research | Chicago | Illinois | 60608 | — |
| Riley Hospital for Children | Indianapolis | Indiana | 46202 | — |
| Kennedy Krieger Institute | Baltimore | Maryland | 21205 | — |
| Boston Children's Hospital | Boston | Massachusetts | 02115 | — |
| University of Massachusetts | Worcester | Massachusetts | 01605 | — |
| University of Missouri, Thompson Research Center for Autism & Neurodevelpmental Disorders | Columbia | Missouri | 65211 | — |
| Seaver Autism Center, Mount Sinai Medical Center | New York | New York | 10029 | — |
| University of North Carolina Neurosciences Hospital | Chapel Hill | North Carolina | 27514 | — |
| Akron Children's Hospital | Akron | Ohio | 44308 | — |
| Cutting Edge Research | Oklahoma City | Oklahoma | 73116 | — |
| Summit Research Network | Portland | Oregon | 97210 | — |
| Suburban Research Associates | Media | Pennsylvania | 19063 | — |
| Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | — |
| University of Tennessee Medical Group, LeBonheur Children's Hospital | Memphis | Tennessee | 38103 | — |
| Vanderbilt Kennedy Center | Nashville | Tennessee | 37203 | — |
| Red Oaks Psychiatry Associates, P.A. | Houston | Texas | 77090 | — |
| Road Runner Research | San Antonio | Texas | 78258 | — |
| Seattle Children's Hospital | Seattle | Washington | 98101 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01288716, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 30, 2013 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01288716 live on ClinicalTrials.gov.